Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
115.86 USD | +0.53% | -1.68% | +6.27% |
12/09 | Merck Says Health Canada Approved Keytruda as Treatment for Hard-to-Treat Solid Tumors | MT |
11/09 | Merck: positive results for HPV vaccine | CF |
EPS & Dividend: Merck & Co., Inc.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Dividend per Share 2 | 2.26 | 2.48 | 2.64 | 2.8 | 2.96 | 3.075 | 3.232 | 3.392 |
Rate of return | 2.48% | 3.03% | 3.44% | 2.52% | 2.72% | 2.65% | 2.79% | 2.93% |
EPS 2 | 3.81 | 2.78 | 5.14 | 5.71 | 0.14 | 7.499 | 9.027 | 10.02 |
Distribution rate | 59.3% | 89.2% | 51.4% | 49% | 2,114% | 41% | 35.8% | 33.9% |
Reference price 2 | 90.95 | 81.80 | 76.64 | 110.95 | 109.02 | 115.86 | 115.86 | 115.86 |
Nbr of stocks (in thousands) | 25,45,984 | 25,30,034 | 25,25,944 | 25,35,396 | 25,34,023 | 25,34,809 | - | - |
Announcement Date | 05/02/20 | 04/02/21 | 03/02/22 | 02/02/23 | 01/02/24 | - | - | - |
Past dividends: Merck & Co., Inc.
Today | Quarterly 0.77 USD |
17/06/2024 | Quarterly 0.77 USD |
14/03/2024 | Quarterly 0.77 USD |
14/12/2023 | Quarterly 0.77 USD |
14/09/2023 | Quarterly 0.73 USD |
14/06/2023 | Quarterly 0.73 USD |
14/03/2023 | Quarterly 0.73 USD |
14/12/2022 | Quarterly 0.73 USD |
14/09/2022 | Quarterly 0.69 USD |
14/06/2022 | Quarterly 0.69 USD |
14/03/2022 | Quarterly 0.69 USD |
14/12/2021 | Quarterly 0.69 USD |
14/09/2021 | Quarterly 0.65 USD |
14/06/2021 | Quarterly 0.65 USD |
12/03/2021 | Quarterly 0.65 USD |
14/12/2020 | Quarterly 0.65 USD |
14/09/2020 | Quarterly 0.61 USD |
12/06/2020 | Quarterly 0.61 USD |
13/03/2020 | Quarterly 0.61 USD |
Upcoming events: Merck & Co., Inc.
Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
---|---|---|---|---|---|---|
+2.65% | +2.79% | 15.45x | 5.984 | 4.91x | ||
+0.56% | +0.65% | 59.56x | 41.04 | 18.45x | ||
+1.24% | +1.64% | 40.44x | 28.34 | 14.09x | ||
+2.83% | +3.10% | 22.5x | 5.640 | 4.58x | ||
+3.21% | +3.32% | 37.8x | 41.05 | 7.16x | ||
+3.71% | +3.81% | 15.86x | 5.878 | 3.76x | ||
+1.98% | +2.08% | 28.09x | 5.777 | 5.05x | ||
+3.26% | +3.39% | 21.48x | 5.253 | 4.95x | ||
+2.76% | +2.98% | 51.21x | 35.60 | 6.89x | ||
+5.69% | +5.80% | 21.49x | 1.892 | 3.69x | ||
Average | +2.79% | +2.96% | 31.39x | 17.65 | 7.35x | |
Weighted average by Cap. | +2.21% | +2.39% | 36.39x | 22.61 | 9.81x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition